|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/505 | |
| A61K 31/55 | |||
| A61K 38/17 | |||
| A61P 35/00 |
| (11) | Number of the document | 3050566 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16156335.8 |
| Date of filing the European patent application | 2008-09-10 | |
| (97) | Date of publication of the European application | 2016-08-03 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-28 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 971144 P | 2007-09-10 | US | |
| 13372 | 2007-12-13 | US |
| (72) |
LI, Chiang, Jia, US
JIANG, Zhiwei, US
ROGOFF, Harry, US
LI, Youzhi, US
LIU, Jifeng, US
LI, Wei, US
|
| (73) |
Boston Biomedical, Inc.,
640 Memorial Drive, Cambridge, MA 02139,
US
|
| (54) | A NOVEL GROUP OF STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL PATHWAY INHIBITORS |
| A NOVEL GROUP OF STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL PATHWAY INHIBITORS |